Fasciitis Complicating Subcutaneous Injection of Interferon Beta
Canadian Journal of Gastroenterology, 2000 Data pertaining to 65 patients treated at the Health Sciences Center Hepatology Research Unit in Winnipeg, Manitoba describing local complications related to subcutaneous interferon (IFN) injection administered to treat hepatitis C virus infection are ...
Curtis L Cooper +2 more
doaj +1 more source
Mechanisms of interferon-beta-induced inhibition ofToxoplasma gondiigrowth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1 [PDF]
, 2015 Motamed Elsayed Mahmoud +4 more
openalex +1 more source
Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain) [PDF]
, 1996 Reinhard Dummer +6 more
openalex +1 more source
Evolving expectations around early management of multiple sclerosis
Therapeutic Advances in Neurological Disorders, 2010 Multiple sclerosis is a progressive inflammatory disease of the central nervous system. With prevention or at least delay of disease progression as a key target in the management of multiple sclerosis, current opinion on treatment encourages early ...
Ralf Gold +3 more
doaj +1 more source
Possible role of the Nipah virus V protein in the regulation of the interferon beta induction by interacting with UBX domain-containing protein1 [PDF]
, 2018 Shotaro Uchida +4 more
openalex +1 more source
Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
Drug Design, Development and Therapy, 2013 Julien Mahe,1 Aurélie Meurette,2 Anne Moreau,3 Caroline Vercel,2 Pascale Jolliet1,4 1Clinical Pharmacology Department, Institute of Biology, University Hospital, Nantes, France; 2Clinical Nephrology and Immunology Department, University Hospital ...
Mahe J +4 more
doaj
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial [PDF]
, 2013 Patrick Vermersch +15 more
openalex +1 more source
Multiple Sklerose im Kindes- und Jugendalter: Fingolimod versus Interferon beta-1a [PDF]
, 2019 openalex +1 more source
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis [PDF]
, 2015 Jonathan Calkwood +6 more
openalex +1 more source